The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Open accessAbstract
Tumor-associated macrophages (TAMs) are associated with tumor progression and metastasis. Here, we demonstrate for the first time that legumain, a member of the asparaginyl endopeptidase family functioning as a stress protein, overexpressed by TAMs, provides an ideal target molecule. In fact, a legumain-based DNA vaccine served as a tool to prove this point, as it induced a robust CD8+ T cell response against TAMs, which dramatically reduced their density in tumor tissues and resulted in a marked decrease in proangiogenic factors released by TAMs such as TGF-beta, TNF-alpha, MMP-9, and VEGF. This, in turn, led to a suppression of both tumor angiogenesis and tumor growth and metastasis. Importantly, the success of this strategy was demonstrated in murine models of metastatic breast, colon, and non-small cell lung cancers, where 75% of vaccinated mice survived lethal tumor cell challenges and 62% were completely free of metastases. In conclusion, decreasing the number of TAMs in the tumor stroma effectively altered the tumor microenvironment involved in tumor angiogenesis and progression to markedly suppress tumor growth and metastasis. Gaining better insights into the mechanisms required for an effective intervention in tumor growth and metastasis may ultimately lead to new therapeutic targets and better anticancer strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“Indeed, this finding prompted Mantovani and colleagues to suggest that exposure to IL-4 and IL-10 may induce monocytes in tumors to develop into polarized type II or M2 macrophages (24).”
BackgroundTumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., & Condeelis, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,188
Role of tissue stroma in cancer cell invasion
De Wever, O., & Mareel, M. (2003) · The Journal of Pathology · doi:10.1002/path.1398 · Cited by 1,042
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Macrophage activation switching: an asset for the resolution of inflammation
Porcheray, F., Viaud, S., Rimaniol, A.-C., Léone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., & Gras, G. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02934.x · Cited by 840
Giraudo, E., Inoue, M., & Hanahan, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422087 · Cited by 700
Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells
Ceredig, R., Lowenthal, J. W., Nabholz, M., & MacDonald, H. R. (1985) · Nature · doi:10.1038/314098a0 · Cited by 594
Sinha, P., Clements, V. K., & Ostrand-Rosenberg, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.636 · Cited by 466
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
Kusmartsev, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4880 · Cited by 445
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Van Damme, J., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 426
Macrophage Responses to Hypoxia
Lewis, C., & Murdoch, C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62038-x · Cited by 413
Tumor-Associated Macrophages in Breast Cancer
Leek, R. D., & Harris, A. L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020304003704 · Cited by 351
Liu, C., Sun, C., Huang, H., Janda, K. D., & Edgington, T. S. (2003) · PubMed · Cited by 334
Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase.
Chen, J.-M., Dando, P. M., Rawlings, N. D., Brown, M. A., Young, N. E., Stevens, R. A., Hewitt, E., Watts, C., & Barrett, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8090 · Cited by 320
Mantovani, A., Allavena, P., & Sica, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.016 · Cited by 311
Allavena, P., Signorelli, M., Chieppa, M., Erba, E., Bianchi, G., Marchesi, F., Olimpio, C. O., Bonardi, C., Garbi, A., Lissoni, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4037 · Cited by 286
Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., & Thompson, T. C. (2000) · PubMed · Cited by 271
A chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E. I., & Balkwill, F. R. (2003) · PubMed · Cited by 259
Barberá‐Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C., & Sampsel, J. W. (2002) · PubMed · Cited by 233
Protease-Activated Receptors (PAR1 and PAR2) Contribute to Tumor Cell Motility and Metastasis
Shi, X., Gangadharan, B., Brass, L. F., Ruf, W., & Mueller, B. M. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.395.2.7 · Cited by 230
Kembhavi, A. A., Buttle, D. J., Knight, C. G., & Barrett, A. J. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1274 · Cited by 183
MMP9 potentiates pulmonary metastasis formation
van Kempen, L. C. L., & Coussens, L. M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00157-5 · Cited by 162
Saio, M., Radoja, S., Marino, M., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5583 · Cited by 157
An autologous oral DNA vaccine protects against murine melanoma
Xiang, R., Lode, H. N., Chao, T.-H., Ruehlmann, J. M., Dolman, C. S., Rodrı́guez, F., Whitton, J. L., Overwijk, W. W., Restifo, N. P., & Reisfeld, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090097697 · Cited by 156
Tumor Rejection by Disturbing Tumor Stroma Cell Interactions
Ibe, S., Qin, Z., Schüler, T., Preiß, S., & Blankenstein, T. J. F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1549 · Cited by 149
Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue
Silzle, T., Kreutz, M. P., Dobler, M. A., Brockhoff, G., Knuechel, R., & Kunz‐Schughart, L. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323057 · Cited by 145
Kuroda, E., & Yamashita, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.757 · Cited by 130
Macrophages direct tumour histology and clinical outcome in a colon cancer model
Oosterling, S. J., van der Bij, G. J., Meijer, G. A., Tuk, C. W., van Garderen, E., van Rooijen, N., Meijer, S., van der Sijp, J. R., Beelen, R. H. J., & van Egmond, M. (2005) · The Journal of Pathology · doi:10.1002/path.1830 · Cited by 130
Macrophages: Modulators of Breast Cancer Progression
Lin, E. Y., & Pollard, J. W. (2004) · Novartis Foundation symposium · doi:10.1002/0470856734.ch12 · Cited by 127
Legumain Expression in Relation to Clinicopathologic and Biological Variables in Colorectal Cancer
Murthy, R. V., Arbman, G., Gao, J., Roodman, G. D., & Sun, X.-F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1642 · Cited by 121
Inflammation and cancer: the long reach of Ras
Karin, M. (2005) · Nature Medicine · doi:10.1038/nm0105-20 · Cited by 109
Schlereth, A., Becker, C., Horstmann, C., Tiedemann, J., & Müntz, K. (2000) · Journal of Experimental Botany · doi:10.1093/jexbot/51.349.1423 · Cited by 84
Markers of macrophage differentiation in experimental silicosis
Misson, P., van den Brûle, S., Barbarin, V., Lison, D., & Huaux, F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0104019 · Cited by 81
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity
Emens, L. A., Reilly, R. T., & Jaffee, E. M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00671 · Cited by 80
Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine
Luo, Y., Zhou, H., Mizutani, M., Mizutani, N., Reisfeld, R. A., & Xiang, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1033132100 · Cited by 76
Self-citationMantovani, A., Sozzani, S., Locati, M., Schioppa, T., Saccani, A., Allavena, P., & Sica, A. (2004) · Novartis Foundation symposium · doi:10.1002/0470856734.ch10 · Cited by 75
Macrophage Infiltration and Angiogenesis in Human Malignancy
Knowles, H. J., Leek, R., & Harris, A. L. (2004) · Novartis Foundation symposium · doi:10.1002/0470856734.ch14 · Cited by 69
T cell–mediated suppression of angiogenesis results in tumor protective immunity
Zhou, H., Luo, Y., Mizutani, M., Mizutani, N., Reisfeld, R. A., & Xiang, R. (2005) · Blood · doi:10.1182/blood-2005-03-0969 · Cited by 43
Self-citationTumor associated macrophages in breast cancer
Carpenco, E. (2019) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.2590002 · Cited by 39
Cited by
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
Metadata
- Authors
- Luo, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-08-01
- Volume
- 116
- Issue
- 8
- Pages
- 2132-2141
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2167685929
- Cited by
- 552
- References
- 46
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.